Biogen's Spinraza Receives FDA Approval, Becomes First Drug For Spinal Muscular Atrophy

The United States now has its first spinal muscular atrophy drug. The FDA has approved Biogen's Spinraza (nusinersen) on Dec. 23 as treatment for the rare and often fatal genetic disease affecting both children and adults.